Dr. Jeremy Sharp sits down with Dr. Amber Vernon for this course to talk about guardianship and conservatorship evaluations. This course dives deep into:
Dr. Vernon’s personal experience with capacity and decision-making
Legal aspects and definitions relevant to these evaluations
Levels of decision-making
What guardianship proceedings typically look like
What these evaluations are NOT
Interview conducted: November 2022
CE Content Category: Testing/Assessment/General
Target audience: Psychologists, mental health counselors, marriage and family therapists, social workers, addiction counselors, nurses, case managers.
This CE course is designated as beginner.
There is no known conflict of interest or commercial support.
Asynchronous, distance learning. Non-interactive. Recorded audio with transcript.
Marijuana products have greater potency and higher levels of tetrahydrocannabinol (THC) than ever before. THC levels in marijuana products are regularly exceeding 20%, but this is mild in comparison to various and popular types of cannabis concentrates collectively known as “dabs".
According to studies compiled by the National Institutes of Health, high concentrations of THC can increase a person's risk of experiencing psychosis.
As a result, mental health specialists are faced with a clinical dilemma - how to clearly identify a substance-induced psychosis from a primary psychotic illness or a psychotic illness with comorbid substance use. This could possibly be a subtle conundrum and a chance for elucubration, yet it becomes vastly more important when treating and choosing the best therapeutic strategy for patients.
So, for this course, Dr. Jeremy Sharp sits down with Craig Heacock to take a deep dive into substance-induced psychosis. Here are a few discussion points that come up:
What exactly is substance-induced psychosis?
Is it qualitatively different than “regular” psychosis?
What are the risk factors for developing substance-induced psychosis?
What is the prognosis after a substance-induced psychotic break?
Target audience: Psychologists, mental health counselors, marriage and family therapists, social workers, addiction counselors, nurses.
Content Category: Testing/Assessment/Clinical; Clinical Assessment; Treatment Plan; Discharge and Continuing Care
This CE course is designated as intermediate.
This interview was published in November of 2022.
Conflict of interest or commercial support disclaimer: There are no conflicts of interest to report
NAADAC Participants: Participants earning NAADAC approved CE credits for online courses will be limited to eight (8) hours of credit within a twenty-four (24) hour period.
Asynchronous, distance learning. Non-interactive. Recorded audio with transcript.
“I feel much more confident in my interpretation if I predicted it in advance.”
For this course, Dr. Joel Schneider, with his characteristic blend of humor, storytelling, and clinical acumen, sits down with Dr. Jeremy Sharp to discuss “robust interpretation practices” – Joel’s term for being diligent and mindful of test construction, score distribution, base rates, and other often-overlooked factors that should be considered when interpreting assessment data.
Interview conducted: December 2022
CE Content Category: Testing/Assessment; Clinical
Target audience: Psychologists, mental health counselors, marriage and family therapists, addiction counselors, nurses, case managers.
This course does not offer CE for Social Workers
This course does not offer NAADAC CE credit
This CE course is designated as intermediate.
Conflict of interest or commercial support disclaimer: Dr. Schneider, along with Kevin McGrew, has co-authored the most recent updates to the Cattell-Horn-Carroll Theory of Cognitive Abilities (Schneider & McGrew, 2018). He also co-authored the second edition of Essentials of Assessment Report Writing (Schneider, Lichtenberger, Mather, & Kaufman, 2018).
This course includes an audio file and a written transcript.
